Yahoo Web Search

Search results

  1. Targeting unmet. medical needs. Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets (OligoPhore™ / SemaPhore™ delivery platforms). The Company currently has two flagship siRNA programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for ...

    • About

      Thomas Meyer founded Auris Medical (renamed Altamira...

    • RNA Programs

      Altamira’s OligoPhore™ / SemaPhore™ platform is a versatile...

    • Legacy Programs

      The legacy programs of Altamira comprise Bentrio ®, an...

  2. ALTAMIRA MEDIA Headquartered in Southern California with associates located in Los Angeles, Miami, Caracas, and Mexico City. MAIN OFFICE: 1+ ‪(805) 232-3133‬ SKYPE: habraham1

  3. The Cave of Altamira ( / ˌæltəˈmɪərə / AL-tə-MEER-ə; Spanish: Cueva de Altamira [ˈkweβa ðe altaˈmiɾa]) is a cave complex, located near the historic town of Santillana del Mar in Cantabria, Spain. It is renowned for prehistoric cave art featuring charcoal drawings and polychrome paintings of contemporary local fauna and ...

  4. altamira media Headquartered in Southern California with associates located in Los Angeles, Miami, Caracas, and Mexico City. MAIN OFFICE: 1+ ‪(805) 232-3133‬

  5. Publications featuringAltamira. Publications featuring. Altamira. Peptide-Based Nonoparticles for Extrahepatic Delivery of Therapeutic #RNA. Chimica Oggi/Chemistry Today, 2023, vol.41 (6) LINK. Targeting Cancer with RNA Therapeutics. DDN, September 2021, Volume 17, Issue 9. Download.

  6. Altamira, cave in northern Spain famous for its magnificent prehistoric paintings and engravings. It is situated 19 miles (30 km) west of the port city of Santander, in Cantabria provincia. Altamira was designated a UNESCO World Heritage site in 1985.

  7. Jun 15, 2023 · Investors & Media. Release Details. Altamira Therapeutics Announces IND Clearance by U.S. FDA for AM-125 in Acute Vestibular Syndrome. June 15, 2023. PDF Version.